Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/1/03 → 10/31/04 |
Funding
- Bristol Myers Squibb Company: $10,875.00
A Phase II Randomized Non-Comparative Trial of Irinotecan and Carboplatin Vs. Irontecan in Subjects 1-21 Years of Age with Refractory Solid Tumors
- Greenwood Cassidy, Martha (PI)
- Bayliff, Sherry (CoI)
- Geil, John (CoI)
- MANKAD, VIPUL (CoI)
- Moscow, Jeffrey (CoI)